MeSH tree: A15.145.229.637.555.567.569.500
Creatine, the organic acid that is popularly taken as a supplement by athletes and bodybuilders, supercharges a critical class of immune cells that activate and prepare the body's key cancer-fighters, according to new UCLA ...
3 hours ago
1
12
Immunotherapies such as so-called checkpoint inhibitors activate the body's own immune system to fight cancer cells and have revolutionized the treatment of many types of tumor. In breast cancer, however, these therapies ...
May 27, 2026
0
21
A novel spatial transcriptomics atlas developed by Northwestern Medicine scientists may improve the understanding of niche cellular interactions in the gastrointestinal tract that promote the development of inflammatory bowel ...
May 20, 2026
0
26
Inflammatory bowel diseases occur when the delicate balance between the gut, the immune system, and the microbiota is disrupted. Until now, however, it was unclear whether harmful microbes or defects in the body's own immune ...
May 18, 2026
0
24
Researchers from the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) have reached a significant advance in the fight against type 1 diabetes. Using an innovative hydrogel that supports insulin-producing ...
May 18, 2026
0
16
Until recently, allergy treatment was largely based on average treatment schemes. A patient with pollen allergy would receive a similar therapy to others with the same diagnosis. Today, this model is beginning to change. ...
May 8, 2026
0
4
Cancer immunotherapy is built on a simple but powerful idea: the immune system can recognize and destroy cancer cells if it is properly activated. In many patients, however, this response is too weak or too slow to be effective. ...
May 7, 2026
0
7
Cytotoxic T lymphocytes are the body's specialized "killer" cells, precisely eliminating infected or cancerous cells. Their action relies on a specialized exchange zone called the "immune synapse," where they release active ...
Apr 29, 2026
0
5
Researchers at Oregon Health & Science University have uncovered a key reason why immunotherapy has largely failed in pancreatic cancer—and identified a promising strategy to overcome that resistance. The study, published ...
Apr 10, 2026
0
25
The application of CAR immunotherapies to neurodegenerative diseases is limited by major challenges due to the complex nature of these pathologies and the heterogeneity of harmful molecules to be treated. Nonetheless, and ...
Apr 8, 2026
0
3
